JPMORGAN CHASE & CO - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 51 filers reported holding CENTURY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,046
-19.0%
26,523
+28.0%
0.00%
Q2 2023$65,463
-71.3%
20,716
-68.5%
0.00%
Q1 2023$228,000
+67959.7%
65,752
+0.4%
0.00%
Q4 2022$335
-99.9%
65,461
+3.7%
0.00%
Q3 2022$624,000
+13.9%
63,101
-3.5%
0.00%
Q2 2022$548,000
-26.3%
65,356
+10.5%
0.00%
Q1 2022$744,000
-66.7%
59,119
-58.1%
0.00%
Q4 2021$2,235,000
+40.0%
140,953
+122.2%
0.00%
Q3 2021$1,596,00063,4240.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,307,407$2,614,8140.81%
Casdin Capital, LLC 3,206,380$6,412,7600.71%
Parametrica Management Ltd 27,840$55,6800.09%
Avidity Partners Management LP 1,098,500$2,197,0000.09%
Deep Track Capital, LP 543,008$1,086,0160.04%
HARBOURVEST PARTNERS LLC 29,018$58,0360.02%
CORNERCAP INVESTMENT COUNSEL INC 51,520$103,0400.02%
Baker Brothers Advisors 1,149,340$2,298,6800.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 165,000$330,0000.01%
FEDERATED HERMES, INC. 615,982$1,231,9640.00%
View complete list of CENTURY THERAPEUTICS INC shareholders